logo
  • Home
  • News
Menu

Moderna, BioNTech Lose $60 Billion in Value in Two-Day Drop

Home / Stock Analysis / Moderna, BioNTech Lose $60 Billion in Value in Two-Day Drop
Article feature image

Moderna, BioNTech Lose $60 Billion in Value in Two-Day Drop

11 Aug Stock Analysis

(Bloomberg) — Moderna Inc. and BioNTech SE, the worlds leading Covid-19 vaccine makers, tumbled for the second day in a row, losing roughly $60 billion in combined market value as investors balked at the companies lofty valuations.
The declines deepened…

Click here to view the original article.

Tags:
Global, Yahoo Entertainment
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1585186659638.jpeg
+

Is Zimmer Biomet (ZBH) Offering An Opportunity After Multi Year Share Price Weakness

15 Jan Stock Analysis
1585186774276.jpeg
+

LigaChem Biosciences Inc.’s (KOSDAQ:141080) stock price dropped 9.0% last week; individual investors would not be happy

15 Jan Stock Analysis

recent post

  • 1585186659638.jpeg

    Is Zimmer Biomet (ZBH) Offering An

    Jan 15 2026
  • hash_asset_management.jpg

    HASH Asset Management’s Lawsuit vs. ICHI

    Jan 15 2026
  • 1585186774276.jpeg

    LigaChem Biosciences Inc.’s (KOSDAQ:141080) stock price

    Jan 15 2026
  • 843cdc105834223efecb537bc85fa82d.jpeg

    Coinbase cannot support crypto bill in

    Jan 15 2026
  • 1585186558401.jpeg

    Assessing RPC (RES) Valuation As Share

    Jan 15 2026

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.